Innate immunity markers in culprit plaques of acute myocardial infarction or stable angina

References

• Bottazzi B, Vouret-Craviari V, Bastone A, De Gioia L, Matteucci C, Peri G, Spreafico F, Pausa M, D’Ettorre C, Gianazza E, Tagliabue A, Salmona M, Tedesco F, Introna M, Mantovani A. (1997). Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 272:32817–32823.
   PubMed Web of Science ®Google Scholar
• Dangas G, Mehran R, Duvvuri S, Vidhun R, Ambrose JA, Sharma SK. (1998). Directional coronary atherectomy in acute myocardial infarction. Cardiology 90:63–66.
   PubMed Web of Science ®Google Scholar
• Deban L, Bottazzi B, Garlanda C, de la Torre YM, Mantovani A. (2009). Pentraxins: multifunctional proteins at the interface of innate immunity and inflammation. Biofactors 35:138–145.
   PubMed Web of Science ®Google Scholar
• Falk E, Shah PK, Fuster V. (1995). Coronary plaque disruption. Circulation 92:657–671.
   PubMed Web of Science ®Google Scholar
• Han KH, Hong KH, Park JH, Ko J, Kang DH, Choi KJ, Hong MK, Park SW, Park SJ. (2004). C-reactive protein promotes monocyte chemoattractant protein-1–mediated chemotaxis through upregulating CC chemokine receptor 2 expression in human monocytes. Circulation 109:2566–2571.
   PubMed Web of Science ®Google Scholar
• Inoue K, Sugiyama A, Reid PC, Ito Y, Miyauchi K, Mukai S, Sagara M, Miyamoto K, Satoh H, Kohno I, Kurata T, Ota H, Mantovani A, Hamakubo T, Daida H, Kodama T. (2007). Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 27:161–167.
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Hatakeyama K, Imamura T, Date H, Shibata Y, Hikichi Y, Asada Y, Eto T. (2003). Involvement of C-reactive protein obtained by directional coronary atherectomy in plaque instability and developing restenosis in patients with stable or unstable angina pectoris. Am J Cardiol 91:287–292.
   PubMed Web of Science ®Google Scholar
• Koenig W, Khuseyinova N. (2007). Biomarkers of atherosclerotic plaque instability and rupture. Arterioscler Thromb Vasc Biol 27:15–26.
   PubMed Web of Science ®Google Scholar
• Kovanen PT, Kaartinen M, Paavonen T. (1995). Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92:1084–1088.
   PubMed Web of Science ®Google Scholar
• Krupinski J, Turu MM, Martinez-Gonzalez J, Carvajal A, Juan-Babot JO, Iborra E, Slevin M, Rubio F, Badimon L. (2006). Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 37:1200–1204.
   PubMed Web of Science ®Google Scholar
• Kurisu S, Sato H, Tateishi H, Kawagoe T, Ishihara M, Shimatani Y, Sakai K, Ueda K, Matsuura H. (1997). Directional coronary atherectomy for the treatment of acute myocardial infarction. Am Heart J 134:345–350.
   PubMed Web of Science ®Google Scholar
• Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE. (1999). C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 100:96–102.
   PubMed Web of Science ®Google Scholar
• Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D, Tarli L, Schweiger C, Fresco C, Cecere R, Tognoni G, Mantovani A; Lipid Assessment Trial Italian Network (LATIN) Investigators. (2004). Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 110:2349–2354.
   PubMed Web of Science ®Google Scholar
• Libby P. (1995). Molecular bases of the acute coronary syndromes. Circulation 91:2844–2850.
   PubMed Web of Science ®Google Scholar
• Loftus IM, Naylor AR, Goodall S, Crowther M, Jones L, Bell PR, Thompson MM. (2000). Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke 31:40–47.
   PubMed Web of Science ®Google Scholar
• Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, Maly FE, Sütsch G, Roffi M, Neidhart M, Eberli FR, Tanner FC, Gobbi S, von Eckardstein A, Lüscher TF. (2005). Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111:1355–1361.
   PubMed Web of Science ®Google Scholar
• Matsubara J, Sugiyama S, Nozaki T, Sugamura K, Konishi M, Ohba K, Matsuzawa Y, Akiyama E, Yamamoto E, Sakamoto K, Nagayoshi Y, Kaikita K, Sumida H, Kim-Mitsuyama S, Ogawa H. (2011). Pentraxin 3 is a new inflammatory marker correlated with left ventricular diastolic dysfunction and heart failure with normal ejection fraction. J Am Coll Cardiol 57:861–869.
   PubMed Web of Science ®Google Scholar
• McKnight J, Studeny M, Roberts G, Touchon R, Wehner P. (2001). Directional coronary atherectomy in acute myocardial infarction. W V Med J 97:109–110.
   PubMedGoogle Scholar
• Montero I, Orbe J, Varo N, Beloqui O, Monreal JI, Rodríguez JA, Díez J, Libby P, Páramo JA. (2006). C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47:1369–1378.
   PubMed Web of Science ®Google Scholar
• Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. (1994). Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 90:775–778.
   PubMed Web of Science ®Google Scholar
• Matsui S, Ishii J, Kitagawa F, Kuno A, Hattori K, Ishikawa M, Okumura M, Kan S, Nakano T, Naruse H, Tanaka I, Nomura M, Hishida H, Ozaki Y. (2010). Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 210:220–225.
   PubMed Web of Science ®Google Scholar
• Norata GD, Marchesi P, Pulakazhi Venu VK, Pasqualini F, Anselmo A, Moalli F, Pizzitola I, Garlanda C, Mantovani A, Catapano AL. (2009). Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis. Circulation 120:699–708.
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG. (2009). Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere. Curr Opin Lipidol 20:393–401.
   PubMed Web of Science ®Google Scholar
• Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J. (2001). Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534.
   PubMed Web of Science ®Google Scholar
• Savchenko A, Imamura M, Ohashi R, Jiang S, Kawasaki T, Hasegawa G, Emura I, Iwanari H, Sagara M, Tanaka T, Hamakubo T, Kodama T, Naito M. (2008). Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol 215:48–55.
   PubMed Web of Science ®Google Scholar
• Singh U, Dasu MR, Yancey PG, Afify A, Devaraj S, Jialal I. (2008). Human C-reactive protein promotes oxidized low density lipoprotein uptake and matrix metalloproteinase-9 release in Wistar rats. J Lipid Res 49:1015–1023.
   PubMed Web of Science ®Google Scholar
• Tennent GA, Hutchinson WL, Kahan MC, Hirschfield GM, Gallimore JR, Lewin J, Sabin CA, Dhillon AP, Pepys MB. (2008). Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice. Atherosclerosis 196:248–255.
   PubMed Web of Science ®Google Scholar
• Torzewski M, Reifenberg K, Cheng F, Wiese E, Küpper I, Crain J, Lackner KJ, Bhakdi S. (2008). No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice. Thromb Haemost 99:196–201.
   PubMed Web of Science ®Google Scholar
• van der Wal AC, Becker AE, van der Loos CM, Das PK. (1994). Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36–44.
   PubMed Web of Science ®Google Scholar
• Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. (2000). Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262–1275.
   PubMed Web of Science ®Google Scholar
• Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. (2008). Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med. 359:1897–1908.
   PubMed Web of Science ®Google Scholar